Reliability and sensitivity to change of the Bristol Rheumatoid Arthritis Fatigue scales

被引:45
|
作者
Dures, Emma K. [1 ]
Hewlett, Sarah E. [1 ]
Cramp, Fiona A. [1 ]
Greenwood, Rosemary [2 ]
Nicklin, Joanna K. [1 ]
Urban, Marie [2 ]
Kirwan, John R. [3 ]
机构
[1] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England
[2] Univ Hosp Bristol, Res Design Serv, Bristol, Avon, England
[3] Univ Bristol, Fac Med & Dent, Bristol, Avon, England
关键词
rheumatoid arthritis; fatigue; patient-reported outcome; reliability; sensitivity; MCID; PATIENT-REPORTED OUTCOMES; VISUAL ANALOG SCALES; CULTURAL-ADAPTATION; SELF-MANAGEMENT; HEALTH-STATUS; ASSOCIATION; EXPERIENCE; AGREEMENT; IMPACT;
D O I
10.1093/rheumatology/ket218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine the reliability (stability) and sensitivity of the Bristol Rheumatoid Arthritis Fatigue scales (BRAFs) and patient-reported outcome measures (PROMs) developed to capture the fatigue experience. The Multi-Dimensional Questionnaire (BRAF-MDQ) has a global score and four subscales (Physical Fatigue, Living with Fatigue, Cognitive Fatigue and Emotional Fatigue), while three numerical rating scales (BRAF-NRS) measure fatigue Severity, Effect and Coping. Methods. RA patients completed the BRAFs plus comparator PROMs. Reliability (study 1): 50 patients completed questionnaires twice. A same-day test-retest interval (minimum 60 min) ensured both time points related to the same 7 days, minimizing the capture of fatigue fluctuations. Reliability (study 2): 50 patients completed the same procedure with a re-worded BRAF-NRS Coping. Sensitivity to change (study 3): 42 patients being given clinically a single high dose of i.m. glucocorticoids completed questionnaires at weeks 0 and 2. Results. The BRAF-MDQ, its subscales and the BRAF-NRS showed very strong reliability (r = 0.82-0.95). BRAF-NRS Coping had lower moderate reliability in both wording formats (r = 0.62, 0.60). The BRAF-MDQ, its subscales and the BRAF-NRS Severity and Effect were sensitive to change, with effect sizes (ESs) of 0.33-0.56. As hypothesized, the BRF-NRS Coping was not responsive to the pharmaceutical intervention (ES 0.05). Preliminary exploration suggests a minimum clinically important difference of 17.5% for improvement and 6.1% for fatigue worsening. Conclusion. The BRAF scales show good reliability and sensitivity to change. The lack of BRAF-NRS Coping responsiveness to medication supports the theory that coping with fatigue is a concept distinct from severity and effect that is worth measuring separately.
引用
收藏
页码:1832 / 1839
页数:8
相关论文
共 50 条
  • [41] Sensitivity to change of the rheumatoid arthritis self-efficacy scale (RASE).
    Hewlett, S
    Cockshott, Z
    Almeida, C
    Richards, P
    Lowe, R
    Greenwood, R
    Kirwan, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S670 - S671
  • [42] RHEUMATOID ARTHRITIS AND CHRONIC FATIGUE
    Hewitt, Jamie
    Wetherly, Laura
    RHEUMATOLOGY, 2015, 54 : 83 - 83
  • [43] Predictors of fatigue in rheumatoid arthritis
    Druce, Katie L.
    Basu, Neil
    RHEUMATOLOGY, 2019, 58 : 29 - 34
  • [44] Sensitivity to change of the rheumatoid arthritis self-efficacy scale (RASE)
    Hewlett, S
    Cockshott, Z
    Almeida, C
    Richards, P
    Lowe, R
    Greenwood, R
    Kirwan, J
    RHEUMATOLOGY, 2005, 44 : I158 - I158
  • [45] Exercise and Fatigue in Rheumatoid Arthritis
    Balsamo, Sandor
    Diniz, Leonardo R.
    dos Santos-Neto, Leopoldo L.
    da Mota, Licia M. H.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (01): : 57 - 60
  • [46] Fatigue in rheumatoid arthritis patients
    Papastergiou, K.
    Xanthopoulou, A.
    Lavdaniti, M.
    SCIENTIFIC CHRONICLES, 2014, 19 (03) : 254 - 262
  • [47] Measuring fatigue in rheumatoid arthritis
    Stephanie Nikolaus
    Mart A. F. J. van de Laar
    Nature Reviews Rheumatology, 2011, 7 : 562 - 564
  • [48] Management of Fatigue in Rheumatoid Arthritis
    Pope, Janet E.
    RMD OPEN, 2020, 6 (01):
  • [49] Validity, reliability and sensitivity to change of simplified power doppler ultrasonographic assessment of the effect of biological therapy on rheumatoid arthritis joint inflammation
    Naredo, E.
    Rodriguez, M.
    Rodriguez-Heredia, J. M.
    Campos, C.
    Medina, J. A.
    Giner, E.
    Martnez, O.
    Toyos, F. J.
    Ruiz, T.
    Ros, I.
    Pujol, M.
    Miquel, X.
    Garcia, L.
    Aznar, J. J.
    Chamizo, E.
    Paez, M.
    Morales, P.
    Rueda, A.
    Tuneu, R.
    Corominas, H.
    Minguez, D.
    Garrido, J.
    Willisch, A.
    Aragon, A.
    Iglesias, G.
    Valdazo, J. P.
    Vargas, C.
    Calvo, J.
    Mas, A. J.
    Galindez, E.
    Raya, E.
    Diaz, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 183 - 183
  • [50] Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire (Retraction of vol 31, pg 1065, 2012)
    Waimann, Christian A.
    Dal Pra, Fernando M.
    Marengo, Maria F.
    Schneeberger, Emilce E.
    Gagliardi, Susana
    Maldonado Cocco, Jose A.
    Sanchez, Monica
    Garone, A.
    Chaparro del Moral, Rafael E.
    Rillo, Oscar L.
    Salcedo, Mariana
    Rosa, Javier E.
    Ceballos, F.
    Soriano, Enrique R.
    Citera, Gustavo
    CLINICAL RHEUMATOLOGY, 2013, 32 (12) : 1833 - 1833